Review



renilla control  (Addgene inc)


Bioz Verified Symbol Addgene inc is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 92

    Structured Review

    Addgene inc renilla control
    Renilla Control, supplied by Addgene inc, used in various techniques. Bioz Stars score: 92/100, based on 7 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pls+mp/pLS-SV40-mP-Rluc+(Plasmid+%23106292)/pm42854690-137-25-27
    Average 92 stars, based on 7 article reviews
    renilla control - by Bioz Stars, 2026-11
    92/100 stars

    Images

    Related Articles

    Ubiquitin Proteomics:

    Article Title: Class IIa HDACs forced degradation allows resensitization of oxaliplatin‐resistant FBXW7 ‐mutated colorectal cancer
    Article Snippet: Y27632 analogue Pro‐survival Compound (Sigma‐Aldrich) was added for the first days of organoids culture after thawing. .. pRK5 HA Ubiquitin WT (#17608), pRK5 HA Ubiquitin K48R (#17605), pLIX 403 (#41395), pQCXIP X2 DEST (w270‐1) (#17474), pDONR223 FBXW7 WT (#81795), pDONR223 FBXW7 p.R505C (#81507), pCMV4a‐Flag‐c‐Myc (#102625), pLS‐mP (#81225), and pLS‐SV40‐mP‐EGFP (#137724) were obtained from Addgene (Watertown, MA, USA). pLKO Puro shHDAC4 1 (TRCN0000314667) and 2 (TRCN000004832), pLKO Puro shAMFR (TRCN0000003375), pLKO Puro shFAF2 (TRCN0000004405), pLKO Puro shFBXW7 1 (TRCN0000006555), pLKO Puro shMARCH5 (TRCN0000037015), pLKO Puro shMARCH6 (TRCN0000232719), pLKO Puro shRNF185 (TRCN0000034054), pLKO Puro shMGRN1 (TRCN0000033790), pLKO Puro shSMURF2 (TRCN0000010792), pLKO Puro shTRIM29 (TRCN0000016350), pLKO Puro shRFFL (TRCN0000034077), pLKO Puro shSPOP (TRCN0000139181), pLKO Puro shFBXO28 (TRCN0000180818), pLKO Puro shFBXO38 (TRCN0000133912), pLKO Puro shRHOBTB3 (TRCN0000048644), pLKO Puro shGSK3β (TRCN0000010552), pLKO Puro shBRCA1_1 (TRCN0000010305), and pLKO Puro shBRCA1_2 (TRCN0000009823) were obtained from Sigma‐Aldrich. pFLAG expressing HDAC4 WT, HDAC4 S298D, and HDAC4 deletions were previously described [ ]. .. HDAC4 S215 and S219 mutants were generated by site‐directed mutagenesis (Agilent, Santa Clara, CA, USA) starting from pFLAG HDAC4. pEGFP C1 FBXW7 WT or R505C mutants were obtained by subcloning FBXW7 ORF restricted BglII/EcoRI from pDONR223 into pEGFP C1 linearized with BglII/EcoRI. pLIX 403 FBXW7 WT and pQCXIP X2 DEST FBXW7 R505C constructs were obtained by L/R recombination following the manufacturer instructions (Gateway LR Clonase II Enzyme mix, Thermo Fisher Scientific), using pDONR223 FBXW7 WT or pDONR223 FBXW7 R505C as donor vectors and pLIX 403 or pQCXIP X2 DEST (w270‐1) as acceptors, respectively. pLS‐NR4A2‐EGFP and pLS‐RNF43‐EGFP were generated by PCR‐restriction (XbaI, SbfI) and contain the regulative element of NR4A2 (hg38, chr2:156333669‐156334207), and RNF43 (hg38, chr17:58402341‐58402769), respectively.

    Article Title: Class IIa HDACs forced degradation allows resensitization of oxaliplatin-resistant FBXW7-mutated colorectal cancer.
    Article Snippet: Y27632 analogue Pro-survival Compound (Sigma-Aldrich) was added for the first days of organoids culture after thawing. .. pRK5 HA Ubiquitin WT (#17608), pRK5 HA Ubiquitin K48R (#17605), pLIX 403 (#41395), pQCXIP X2 DEST (w270-1) (#17474), pDONR223 FBXW7 WT (#81795), pDONR223 FBXW7 p.R505C (#81507), pCMV4a-Flag-c-Myc (#102625), pLS-mP (#81225), and pLS-SV40-mP-EGFP (#137724) were obtained from Addgene (Watertown, MA, USA). pLKO Puro shHDAC4 1 (TRCN0000314667) and 2 (TRCN000004832), pLKO Puro shAMFR (TRCN 0000003375), pLKO Puro shFAF2 (TRCN00000044 05), pLKO Puro shFBXW7 1 (TRCN0000006555), pLKO Puro shMARCH5 (TRCN0000037015), pLKO Puro shMARCH6 (TRCN0000232719), pLKO Puro shRNF185 (TRCN0000034054), pLKO Puro shMGRN1 (TRCN0000033790), pLKO Puro shSMURF2 (TRCN 0000010792), pLKO Puro shTRIM29 (TRCN00000 16350), pLKO Puro shRFFL (TRCN0000034077), pLKO Puro shSPOP (TRCN0000139181), pLKO Puro shFBXO28 (TRCN0000180818), pLKO Puro shFBXO38 (TRCN0000133912), pLKO Puro shRHOBTB3 (TRC N0000048644), pLKO Puro shGSK3b (TRC N0000010552), pLKO Puro shBRCA1_1 (TRC N0000010305), and pLKO Puro shBRCA1_2 (TRC N0000009823) were obtained from Sigma-Aldrich. pFLAG expressing HDAC4 WT, HDAC4 S298D, and HDAC4 deletions were previously described [12]. .. HDAC4 S215 and S219 mutants were generated by site-directed mutagenesis (Agilent, Santa Clara, CA, USA) starting from pFLAG HDAC4. pEGFP C1 FBXW7 WT or R505C mutants were obtained by subcloning FBXW7 ORF restricted BglII/EcoRI from pDONR223 into pEGFP C1 linearized with BglII/EcoRI. pLIX 403 FBXW7 WT and pQCXIP X2 DEST FBXW7 R505C constructs were obtained by L/R recombination following the manufacturer instructions (Gateway LR Clonase II Enzyme mix, Thermo Fisher Scientific), using pDONR223 FBXW7 WT or pDONR223 FBXW7 R505C as donor vectors and pLIX 403 or pQCXIP X2 DEST (w270-1) as acceptors, respectively. pLS-NR4A2-EGFP and pLS-RNF43-EGFP were generated by PCR-restriction (XbaI, SbfI) and contain the regulative element of NR4A2 (hg38, chr2:156333669-156334207), and RNF43 (hg38, chr17:58402341-58402769), respectively.

    Expressing:

    Article Title: Class IIa HDACs forced degradation allows resensitization of oxaliplatin‐resistant FBXW7 ‐mutated colorectal cancer
    Article Snippet: Y27632 analogue Pro‐survival Compound (Sigma‐Aldrich) was added for the first days of organoids culture after thawing. .. pRK5 HA Ubiquitin WT (#17608), pRK5 HA Ubiquitin K48R (#17605), pLIX 403 (#41395), pQCXIP X2 DEST (w270‐1) (#17474), pDONR223 FBXW7 WT (#81795), pDONR223 FBXW7 p.R505C (#81507), pCMV4a‐Flag‐c‐Myc (#102625), pLS‐mP (#81225), and pLS‐SV40‐mP‐EGFP (#137724) were obtained from Addgene (Watertown, MA, USA). pLKO Puro shHDAC4 1 (TRCN0000314667) and 2 (TRCN000004832), pLKO Puro shAMFR (TRCN0000003375), pLKO Puro shFAF2 (TRCN0000004405), pLKO Puro shFBXW7 1 (TRCN0000006555), pLKO Puro shMARCH5 (TRCN0000037015), pLKO Puro shMARCH6 (TRCN0000232719), pLKO Puro shRNF185 (TRCN0000034054), pLKO Puro shMGRN1 (TRCN0000033790), pLKO Puro shSMURF2 (TRCN0000010792), pLKO Puro shTRIM29 (TRCN0000016350), pLKO Puro shRFFL (TRCN0000034077), pLKO Puro shSPOP (TRCN0000139181), pLKO Puro shFBXO28 (TRCN0000180818), pLKO Puro shFBXO38 (TRCN0000133912), pLKO Puro shRHOBTB3 (TRCN0000048644), pLKO Puro shGSK3β (TRCN0000010552), pLKO Puro shBRCA1_1 (TRCN0000010305), and pLKO Puro shBRCA1_2 (TRCN0000009823) were obtained from Sigma‐Aldrich. pFLAG expressing HDAC4 WT, HDAC4 S298D, and HDAC4 deletions were previously described [ ]. .. HDAC4 S215 and S219 mutants were generated by site‐directed mutagenesis (Agilent, Santa Clara, CA, USA) starting from pFLAG HDAC4. pEGFP C1 FBXW7 WT or R505C mutants were obtained by subcloning FBXW7 ORF restricted BglII/EcoRI from pDONR223 into pEGFP C1 linearized with BglII/EcoRI. pLIX 403 FBXW7 WT and pQCXIP X2 DEST FBXW7 R505C constructs were obtained by L/R recombination following the manufacturer instructions (Gateway LR Clonase II Enzyme mix, Thermo Fisher Scientific), using pDONR223 FBXW7 WT or pDONR223 FBXW7 R505C as donor vectors and pLIX 403 or pQCXIP X2 DEST (w270‐1) as acceptors, respectively. pLS‐NR4A2‐EGFP and pLS‐RNF43‐EGFP were generated by PCR‐restriction (XbaI, SbfI) and contain the regulative element of NR4A2 (hg38, chr2:156333669‐156334207), and RNF43 (hg38, chr17:58402341‐58402769), respectively.

    Article Title: Class IIa HDACs forced degradation allows resensitization of oxaliplatin-resistant FBXW7-mutated colorectal cancer.
    Article Snippet: Y27632 analogue Pro-survival Compound (Sigma-Aldrich) was added for the first days of organoids culture after thawing. .. pRK5 HA Ubiquitin WT (#17608), pRK5 HA Ubiquitin K48R (#17605), pLIX 403 (#41395), pQCXIP X2 DEST (w270-1) (#17474), pDONR223 FBXW7 WT (#81795), pDONR223 FBXW7 p.R505C (#81507), pCMV4a-Flag-c-Myc (#102625), pLS-mP (#81225), and pLS-SV40-mP-EGFP (#137724) were obtained from Addgene (Watertown, MA, USA). pLKO Puro shHDAC4 1 (TRCN0000314667) and 2 (TRCN000004832), pLKO Puro shAMFR (TRCN 0000003375), pLKO Puro shFAF2 (TRCN00000044 05), pLKO Puro shFBXW7 1 (TRCN0000006555), pLKO Puro shMARCH5 (TRCN0000037015), pLKO Puro shMARCH6 (TRCN0000232719), pLKO Puro shRNF185 (TRCN0000034054), pLKO Puro shMGRN1 (TRCN0000033790), pLKO Puro shSMURF2 (TRCN 0000010792), pLKO Puro shTRIM29 (TRCN00000 16350), pLKO Puro shRFFL (TRCN0000034077), pLKO Puro shSPOP (TRCN0000139181), pLKO Puro shFBXO28 (TRCN0000180818), pLKO Puro shFBXO38 (TRCN0000133912), pLKO Puro shRHOBTB3 (TRC N0000048644), pLKO Puro shGSK3b (TRC N0000010552), pLKO Puro shBRCA1_1 (TRC N0000010305), and pLKO Puro shBRCA1_2 (TRC N0000009823) were obtained from Sigma-Aldrich. pFLAG expressing HDAC4 WT, HDAC4 S298D, and HDAC4 deletions were previously described [12]. .. HDAC4 S215 and S219 mutants were generated by site-directed mutagenesis (Agilent, Santa Clara, CA, USA) starting from pFLAG HDAC4. pEGFP C1 FBXW7 WT or R505C mutants were obtained by subcloning FBXW7 ORF restricted BglII/EcoRI from pDONR223 into pEGFP C1 linearized with BglII/EcoRI. pLIX 403 FBXW7 WT and pQCXIP X2 DEST FBXW7 R505C constructs were obtained by L/R recombination following the manufacturer instructions (Gateway LR Clonase II Enzyme mix, Thermo Fisher Scientific), using pDONR223 FBXW7 WT or pDONR223 FBXW7 R505C as donor vectors and pLIX 403 or pQCXIP X2 DEST (w270-1) as acceptors, respectively. pLS-NR4A2-EGFP and pLS-RNF43-EGFP were generated by PCR-restriction (XbaI, SbfI) and contain the regulative element of NR4A2 (hg38, chr2:156333669-156334207), and RNF43 (hg38, chr17:58402341-58402769), respectively.

    Article Title: Kaposi’s Sarcoma-Associated Herpesvirus Drives a Super-Enhancer-Mediated Survival Gene Expression Program in Primary Effusion Lymphoma
    Article Snippet: .. July/August 2020 Volume 11 Issue 4 e01457-20 mbio.asm.org 16 on A ugust 27, 2020 by guest http://m bio.asm .org/ D ow nloaded from The lentiviral enhancer construct pLS-mP expressing eGFP under the control of a minimal promoter (61) was pLS-mP (a gift from Nadav Ahituv; Addgene plasmid catalog no. 81225). .. An mCherry version of pLS-mP (pLS-mP-mCherry) was made by Gibson assembly of a PCR product containing mCherry (amplified using primers 4546 and 4547) with the AgeI/EcoRI vector fragment of pLS-mP.

    Synthesized:

    Article Title: Regulation of sarcomere formation and function in the healthy heart requires a titin intronic enhancer
    Article Snippet: .. DNA fragments containing sequences of the TTN regulatory elements E0, E1, E2, and E3 were synthesized by Twist Bioscience and subcloned into pLS-mP (Addgene, no. 81225) using the NEBuilder HiFi DNA Assembly Kit (New England Biolabs, E2621S). .. These TTN enhancer plasmids, together with the VSV-G envelope–expressing plasmid pMD2.G (Addgene, no. 12259) and the lentiviral packaging plasmid psPAX2 (Addgene, no. 12260), were cotransfected into HEK293T cells to produce lentivirus.

    Article Title: Regulation of sarcomere formation and function in the healthy heart requires a titin intronic enhancer
    Article Snippet: .. Enhancer reporter assay in hiPSC-CMs DNA fragments containing sequences of the TTN regulatory elements E0, E1, E2, and E3 were synthesized by Twist Bioscience and cloned into pLS-mP (Addgene #81225) using NEBuilder HiFi DNA Assembly Kit (New England Biolabs #E2621S). .. These TTN enhancer plasmids, together with the VSV-G envelope expressing plasmid pMD2.G (Addgene #12259) and the lentiviral packaging plasmid psPAX2 (Addgene #12260) were co-transfected into HEK293T cells to produce lentivirus.

    Plasmid Preparation:

    Article Title: Machine learning dissection of human accelerated regions in primate neurodevelopment.
    Article Snippet: .. To generate pLS-mP-Luc vector (Addgene 106253), minimal promoter and Luciferase gene fragment was amplified using pGL4.23 (Promega) as a template and inserted into pLS-mP (Addgene 81225) replacing with mP-EGFP. .. To generate pLS-SV40-mP-Rluc (Addgene106292), renilla luciferase gene was amplified using pGL4.74 (promega) as a template and inserted into pLS-SV40-mP vector (17) replacing with EGFP gene.

    Article Title: Kaposi’s Sarcoma-Associated Herpesvirus Drives a Super-Enhancer-Mediated Survival Gene Expression Program in Primary Effusion Lymphoma
    Article Snippet: .. July/August 2020 Volume 11 Issue 4 e01457-20 mbio.asm.org 16 on A ugust 27, 2020 by guest http://m bio.asm .org/ D ow nloaded from The lentiviral enhancer construct pLS-mP expressing eGFP under the control of a minimal promoter (61) was pLS-mP (a gift from Nadav Ahituv; Addgene plasmid catalog no. 81225). .. An mCherry version of pLS-mP (pLS-mP-mCherry) was made by Gibson assembly of a PCR product containing mCherry (amplified using primers 4546 and 4547) with the AgeI/EcoRI vector fragment of pLS-mP.

    Luciferase:

    Article Title: Machine learning dissection of human accelerated regions in primate neurodevelopment.
    Article Snippet: .. To generate pLS-mP-Luc vector (Addgene 106253), minimal promoter and Luciferase gene fragment was amplified using pGL4.23 (Promega) as a template and inserted into pLS-mP (Addgene 81225) replacing with mP-EGFP. .. To generate pLS-SV40-mP-Rluc (Addgene106292), renilla luciferase gene was amplified using pGL4.74 (promega) as a template and inserted into pLS-SV40-mP vector (17) replacing with EGFP gene.

    Amplification:

    Article Title: Machine learning dissection of human accelerated regions in primate neurodevelopment.
    Article Snippet: .. To generate pLS-mP-Luc vector (Addgene 106253), minimal promoter and Luciferase gene fragment was amplified using pGL4.23 (Promega) as a template and inserted into pLS-mP (Addgene 81225) replacing with mP-EGFP. .. To generate pLS-SV40-mP-Rluc (Addgene106292), renilla luciferase gene was amplified using pGL4.74 (promega) as a template and inserted into pLS-SV40-mP vector (17) replacing with EGFP gene.

    other:

    Article Title: A systematic evaluation of the design and context dependencies of massively parallel reporter assays.
    Article Snippet: These primers add a sample-specific barcode and Illumina flow cell adaptors.

    Gel Extraction:

    Article Title: A systematic evaluation of the design and context dependencies of massively parallel reporter assays
    Article Snippet: The human STARR-seq library was amplified with pLSmP-AG-2f and pLSmP-AG-5r ( ) for 17 cycles. .. After gel extraction, we cloned the insert into the pLS-mP (Addgene 81225) , which had been linearized with Sbf I and Age I and treated with antarctic phosphatase. ..

    Clone Assay:

    Article Title: A systematic evaluation of the design and context dependencies of massively parallel reporter assays
    Article Snippet: The human STARR-seq library was amplified with pLSmP-AG-2f and pLSmP-AG-5r ( ) for 17 cycles. .. After gel extraction, we cloned the insert into the pLS-mP (Addgene 81225) , which had been linearized with Sbf I and Age I and treated with antarctic phosphatase. ..

    Reporter Assay:

    Article Title: Regulation of sarcomere formation and function in the healthy heart requires a titin intronic enhancer
    Article Snippet: .. Enhancer reporter assay in hiPSC-CMs DNA fragments containing sequences of the TTN regulatory elements E0, E1, E2, and E3 were synthesized by Twist Bioscience and cloned into pLS-mP (Addgene #81225) using NEBuilder HiFi DNA Assembly Kit (New England Biolabs #E2621S). .. These TTN enhancer plasmids, together with the VSV-G envelope expressing plasmid pMD2.G (Addgene #12259) and the lentiviral packaging plasmid psPAX2 (Addgene #12260) were co-transfected into HEK293T cells to produce lentivirus.

    Construct:

    Article Title: Kaposi’s Sarcoma-Associated Herpesvirus Drives a Super-Enhancer-Mediated Survival Gene Expression Program in Primary Effusion Lymphoma
    Article Snippet: .. July/August 2020 Volume 11 Issue 4 e01457-20 mbio.asm.org 16 on A ugust 27, 2020 by guest http://m bio.asm .org/ D ow nloaded from The lentiviral enhancer construct pLS-mP expressing eGFP under the control of a minimal promoter (61) was pLS-mP (a gift from Nadav Ahituv; Addgene plasmid catalog no. 81225). .. An mCherry version of pLS-mP (pLS-mP-mCherry) was made by Gibson assembly of a PCR product containing mCherry (amplified using primers 4546 and 4547) with the AgeI/EcoRI vector fragment of pLS-mP.

    Control:

    Article Title: Kaposi’s Sarcoma-Associated Herpesvirus Drives a Super-Enhancer-Mediated Survival Gene Expression Program in Primary Effusion Lymphoma
    Article Snippet: .. July/August 2020 Volume 11 Issue 4 e01457-20 mbio.asm.org 16 on A ugust 27, 2020 by guest http://m bio.asm .org/ D ow nloaded from The lentiviral enhancer construct pLS-mP expressing eGFP under the control of a minimal promoter (61) was pLS-mP (a gift from Nadav Ahituv; Addgene plasmid catalog no. 81225). .. An mCherry version of pLS-mP (pLS-mP-mCherry) was made by Gibson assembly of a PCR product containing mCherry (amplified using primers 4546 and 4547) with the AgeI/EcoRI vector fragment of pLS-mP.



    Similar Products

    92
    Addgene inc renilla control
    Renilla Control, supplied by Addgene inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pls+mp/pLS-SV40-mP-Rluc+(Plasmid+%23106292)/pm42854690-137-25-27
    Average 92 stars, based on 1 article reviews
    renilla control - by Bioz Stars, 2026-11
    92/100 stars
      Buy from Supplier

    93
    Addgene inc vector pls mp luc
    Vector Pls Mp Luc, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pls+mp/pLS-mP-Luc+(Plasmid+%23106253)/pm42854690-122-2-4
    Average 93 stars, based on 1 article reviews
    vector pls mp luc - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    93
    Addgene inc control lentivirus
    Control Lentivirus, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pls+mp/pLS-SV40-mP-EGFP+(Plasmid+%23137724)/pm42802174-226-28-31
    Average 93 stars, based on 1 article reviews
    control lentivirus - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    93
    Addgene inc pls sv40 mp egfp
    Pls Sv40 Mp Egfp, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pls+mp/pLS-SV40-mP-EGFP+(Plasmid+%23137724)/pmc13008246-149-20-19
    Average 93 stars, based on 1 article reviews
    pls sv40 mp egfp - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    93
    Addgene inc sv40 enhancer sequence
    Sv40 Enhancer Sequence, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pls+mp/pLS-SV40-mP-EGFP+(Plasmid+%23137724)/pmc13008246-149-8-19
    Average 93 stars, based on 1 article reviews
    sv40 enhancer sequence - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    94
    Addgene inc lentiviral vector pls mp
    (A) <t>Lentiviral</t> massively parallel reporter assay (lentiMPRA) to quantify variant-specific effects on transcriptional activity. (B) LentiMPRA transcription efficiencies (z-score) for reference (REF) and alternate (ALT) alleles with significant variant-specific effects ( p <0.05; paired sample t-test; n = 6). ( C ) LentiMPRA transcriptional efficiency (RNA/DNA, norm) for REF and ALT alleles at SCANDAL regions, with cis -regulatory target gene annotated below. p denotes paired sample t-test (n = 6, ±SD). ( D ) LentiMPRA transcriptional efficiency (RNA/DNA, norm) for REF (C) or ALT (T) alleles at rs1432296. ( E ) Genome snapshot of CRISPR-SAM targeting and Micro-Capture-C (MCC) at rs1432296, including SCANDAL effect on target gene REL as curved line. ( F ) REL expression after CRISPR-SAM perturbation for cells containing rs1432296-targeting or non-targeting control sgRNAs. Circular points reflect single cell expression values, while diamonds indicate mean expression values for all cells containing individual sgRNAs where size corresponds to percentage of cells in which the gene was detected. p denotes Benjamini-Hochberg-adjusted SCEPTRE p -value. ( G ) CRISPR-Cas9 Prime-Editing (PE7) in GC B cells to test risk variant-specific effects in situ via quantile-based sorting of target expression and amplicon sequencing. ( H ) rs1432296 ALT (T) allele frequency and REL transcript mean fluorescence intensity (MFI) in prime-edited GC B cells (n=5). Spearman’s rank correlation (ρ) and p -value are shown. ( I ) REL ChIP-seq signal at SCANDAL risk loci and their SCANDAL target promoters. CREs are centred on open chromatin peak or TSS. ( J ) Genome snapshot of REL-bound rs74405933 SCANDAL risk locus, with motifbreakR prediction for A allele effect on REL motif. SCANDAL effect on target gene REL as curved line. ( K ) CD83 expression after CRISPR-SAM perturbation for cells containing rs74405933-targeting or non-targeting control sgRNAs, with formatting as detailed in (F). ( L ) LentiMPRA transcriptional efficiency (RNA/DNA, norm) for REF (G) or ALT (A) alleles at rs74405933. ( M ) rs1432296 ALT (A) allele frequency and CD83 surface expression (MFI) in prime-edited GC B cells (n=5). Spearman’s rank correlation (ρ) and p -value are shown. ( N ) Number of SCANDAL loci bound by REL, denoting enrichment of REL-bound loci within each trait as compared to all SCANDAL loci with gene targets for this trait. ( O ) Binding of SCANDAL target transcription factors (TF) to other SCANDAL loci with targets, showing if the bound locus has the same trait as the locus controlling the TF expression. ( P ) Proposed model of genetic pleiotropy underlying pan-disease autoimmune risk. While cis -regulatory effects on TF expression may be mediated through a GWAS risk variant associated with Trait A, the downstream targets of that TF include many non-coding risk loci (or their regulatory target genes) with genetic associations for different traits.
    Lentiviral Vector Pls Mp, supplied by Addgene inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pls+mp/pLS-mP+(Plasmid+%2381225)/bio_rxiv__64898__2026__03__01__708923-294-6-14
    Average 94 stars, based on 1 article reviews
    lentiviral vector pls mp - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    94
    Addgene inc pl mp
    (A) <t>Lentiviral</t> massively parallel reporter assay (lentiMPRA) to quantify variant-specific effects on transcriptional activity. (B) LentiMPRA transcription efficiencies (z-score) for reference (REF) and alternate (ALT) alleles with significant variant-specific effects ( p <0.05; paired sample t-test; n = 6). ( C ) LentiMPRA transcriptional efficiency (RNA/DNA, norm) for REF and ALT alleles at SCANDAL regions, with cis -regulatory target gene annotated below. p denotes paired sample t-test (n = 6, ±SD). ( D ) LentiMPRA transcriptional efficiency (RNA/DNA, norm) for REF (C) or ALT (T) alleles at rs1432296. ( E ) Genome snapshot of CRISPR-SAM targeting and Micro-Capture-C (MCC) at rs1432296, including SCANDAL effect on target gene REL as curved line. ( F ) REL expression after CRISPR-SAM perturbation for cells containing rs1432296-targeting or non-targeting control sgRNAs. Circular points reflect single cell expression values, while diamonds indicate mean expression values for all cells containing individual sgRNAs where size corresponds to percentage of cells in which the gene was detected. p denotes Benjamini-Hochberg-adjusted SCEPTRE p -value. ( G ) CRISPR-Cas9 Prime-Editing (PE7) in GC B cells to test risk variant-specific effects in situ via quantile-based sorting of target expression and amplicon sequencing. ( H ) rs1432296 ALT (T) allele frequency and REL transcript mean fluorescence intensity (MFI) in prime-edited GC B cells (n=5). Spearman’s rank correlation (ρ) and p -value are shown. ( I ) REL ChIP-seq signal at SCANDAL risk loci and their SCANDAL target promoters. CREs are centred on open chromatin peak or TSS. ( J ) Genome snapshot of REL-bound rs74405933 SCANDAL risk locus, with motifbreakR prediction for A allele effect on REL motif. SCANDAL effect on target gene REL as curved line. ( K ) CD83 expression after CRISPR-SAM perturbation for cells containing rs74405933-targeting or non-targeting control sgRNAs, with formatting as detailed in (F). ( L ) LentiMPRA transcriptional efficiency (RNA/DNA, norm) for REF (G) or ALT (A) alleles at rs74405933. ( M ) rs1432296 ALT (A) allele frequency and CD83 surface expression (MFI) in prime-edited GC B cells (n=5). Spearman’s rank correlation (ρ) and p -value are shown. ( N ) Number of SCANDAL loci bound by REL, denoting enrichment of REL-bound loci within each trait as compared to all SCANDAL loci with gene targets for this trait. ( O ) Binding of SCANDAL target transcription factors (TF) to other SCANDAL loci with targets, showing if the bound locus has the same trait as the locus controlling the TF expression. ( P ) Proposed model of genetic pleiotropy underlying pan-disease autoimmune risk. While cis -regulatory effects on TF expression may be mediated through a GWAS risk variant associated with Trait A, the downstream targets of that TF include many non-coding risk loci (or their regulatory target genes) with genetic associations for different traits.
    Pl Mp, supplied by Addgene inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pls+mp/pLS-mP+(Plasmid+%2381225)/10__3390_slash_cells15020129-63-8-9
    Average 94 stars, based on 1 article reviews
    pl mp - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    Image Search Results


    (A) Lentiviral massively parallel reporter assay (lentiMPRA) to quantify variant-specific effects on transcriptional activity. (B) LentiMPRA transcription efficiencies (z-score) for reference (REF) and alternate (ALT) alleles with significant variant-specific effects ( p <0.05; paired sample t-test; n = 6). ( C ) LentiMPRA transcriptional efficiency (RNA/DNA, norm) for REF and ALT alleles at SCANDAL regions, with cis -regulatory target gene annotated below. p denotes paired sample t-test (n = 6, ±SD). ( D ) LentiMPRA transcriptional efficiency (RNA/DNA, norm) for REF (C) or ALT (T) alleles at rs1432296. ( E ) Genome snapshot of CRISPR-SAM targeting and Micro-Capture-C (MCC) at rs1432296, including SCANDAL effect on target gene REL as curved line. ( F ) REL expression after CRISPR-SAM perturbation for cells containing rs1432296-targeting or non-targeting control sgRNAs. Circular points reflect single cell expression values, while diamonds indicate mean expression values for all cells containing individual sgRNAs where size corresponds to percentage of cells in which the gene was detected. p denotes Benjamini-Hochberg-adjusted SCEPTRE p -value. ( G ) CRISPR-Cas9 Prime-Editing (PE7) in GC B cells to test risk variant-specific effects in situ via quantile-based sorting of target expression and amplicon sequencing. ( H ) rs1432296 ALT (T) allele frequency and REL transcript mean fluorescence intensity (MFI) in prime-edited GC B cells (n=5). Spearman’s rank correlation (ρ) and p -value are shown. ( I ) REL ChIP-seq signal at SCANDAL risk loci and their SCANDAL target promoters. CREs are centred on open chromatin peak or TSS. ( J ) Genome snapshot of REL-bound rs74405933 SCANDAL risk locus, with motifbreakR prediction for A allele effect on REL motif. SCANDAL effect on target gene REL as curved line. ( K ) CD83 expression after CRISPR-SAM perturbation for cells containing rs74405933-targeting or non-targeting control sgRNAs, with formatting as detailed in (F). ( L ) LentiMPRA transcriptional efficiency (RNA/DNA, norm) for REF (G) or ALT (A) alleles at rs74405933. ( M ) rs1432296 ALT (A) allele frequency and CD83 surface expression (MFI) in prime-edited GC B cells (n=5). Spearman’s rank correlation (ρ) and p -value are shown. ( N ) Number of SCANDAL loci bound by REL, denoting enrichment of REL-bound loci within each trait as compared to all SCANDAL loci with gene targets for this trait. ( O ) Binding of SCANDAL target transcription factors (TF) to other SCANDAL loci with targets, showing if the bound locus has the same trait as the locus controlling the TF expression. ( P ) Proposed model of genetic pleiotropy underlying pan-disease autoimmune risk. While cis -regulatory effects on TF expression may be mediated through a GWAS risk variant associated with Trait A, the downstream targets of that TF include many non-coding risk loci (or their regulatory target genes) with genetic associations for different traits.

    Journal: bioRxiv

    Article Title: Single-cell CRISPR activation screens in primary B cells discover gene regulatory mechanisms for hundreds of autoimmune risk loci

    doi: 10.64898/2026.03.01.708923

    Figure Lengend Snippet: (A) Lentiviral massively parallel reporter assay (lentiMPRA) to quantify variant-specific effects on transcriptional activity. (B) LentiMPRA transcription efficiencies (z-score) for reference (REF) and alternate (ALT) alleles with significant variant-specific effects ( p <0.05; paired sample t-test; n = 6). ( C ) LentiMPRA transcriptional efficiency (RNA/DNA, norm) for REF and ALT alleles at SCANDAL regions, with cis -regulatory target gene annotated below. p denotes paired sample t-test (n = 6, ±SD). ( D ) LentiMPRA transcriptional efficiency (RNA/DNA, norm) for REF (C) or ALT (T) alleles at rs1432296. ( E ) Genome snapshot of CRISPR-SAM targeting and Micro-Capture-C (MCC) at rs1432296, including SCANDAL effect on target gene REL as curved line. ( F ) REL expression after CRISPR-SAM perturbation for cells containing rs1432296-targeting or non-targeting control sgRNAs. Circular points reflect single cell expression values, while diamonds indicate mean expression values for all cells containing individual sgRNAs where size corresponds to percentage of cells in which the gene was detected. p denotes Benjamini-Hochberg-adjusted SCEPTRE p -value. ( G ) CRISPR-Cas9 Prime-Editing (PE7) in GC B cells to test risk variant-specific effects in situ via quantile-based sorting of target expression and amplicon sequencing. ( H ) rs1432296 ALT (T) allele frequency and REL transcript mean fluorescence intensity (MFI) in prime-edited GC B cells (n=5). Spearman’s rank correlation (ρ) and p -value are shown. ( I ) REL ChIP-seq signal at SCANDAL risk loci and their SCANDAL target promoters. CREs are centred on open chromatin peak or TSS. ( J ) Genome snapshot of REL-bound rs74405933 SCANDAL risk locus, with motifbreakR prediction for A allele effect on REL motif. SCANDAL effect on target gene REL as curved line. ( K ) CD83 expression after CRISPR-SAM perturbation for cells containing rs74405933-targeting or non-targeting control sgRNAs, with formatting as detailed in (F). ( L ) LentiMPRA transcriptional efficiency (RNA/DNA, norm) for REF (G) or ALT (A) alleles at rs74405933. ( M ) rs1432296 ALT (A) allele frequency and CD83 surface expression (MFI) in prime-edited GC B cells (n=5). Spearman’s rank correlation (ρ) and p -value are shown. ( N ) Number of SCANDAL loci bound by REL, denoting enrichment of REL-bound loci within each trait as compared to all SCANDAL loci with gene targets for this trait. ( O ) Binding of SCANDAL target transcription factors (TF) to other SCANDAL loci with targets, showing if the bound locus has the same trait as the locus controlling the TF expression. ( P ) Proposed model of genetic pleiotropy underlying pan-disease autoimmune risk. While cis -regulatory effects on TF expression may be mediated through a GWAS risk variant associated with Trait A, the downstream targets of that TF include many non-coding risk loci (or their regulatory target genes) with genetic associations for different traits.

    Article Snippet: To clone the MPRA library into lentiviral vector pLS-mP (a gift from Nadav Ahituv; Addgene #81225), 125 ng of the oligonucleotide pool DNA was amplified in 4 × 50 μL reactions with 0.5 μM MPRAlib_PCR1_FW and MPRAlib_PCR1_RV primers and following conditions: 98°C for 1 min, (98°C for 10 s, 60°C for 15 s, 72°C for 20 s) × 5 cycles, 72°C for 5 min. 150 ng of purified PCR product split into 4 × 50 μL reactions and amplified with 0.5 μM MPRAlib_PCR2_FW and MPRAlib_BC_PCR2_RV primers under following conditions: 98°C for 2 min, (98°C for 15 s, 60°C for 20 s, 72°C for 30 s) × 4 cycles, 72°C for 5 min. At this step, a unique 13 bp molecular barcode (from primer MPRA_PCR2_FW) was added to each CRE.

    Techniques: Reporter Assay, Variant Assay, Activity Assay, CRISPR, Capture-C, Expressing, Control, Single Cell, In Situ, Amplification, Sequencing, Fluorescence, ChIP-sequencing, Binding Assay